References
- Graus F, Rogers L R, Posner J B. Cerebrovascular complications in patients with cancer. Medicine 1985; 64: 16–35
- Doll D C, Ringerberg Q S, Yarbro J W. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1985; 4: 1405–7
- Garstin W H, Cooper G G, Hood J M. Arterial thrombosis after treatment with bleomycin and cisplatin. Br Med J 1990; 300: 1018
- Doll D C, List A F, Greco F A, et al. Acute arterial ischemic events following cisplatin-based combination chemotherapy for germ-cells tumors of the testis. Ann Intern Med 1986; 105: 48–51
- Goldhirsch A, Joss R, Markwalder T M, et al. Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone. Oncology 1983; 40: 344–5
- Kornfeld S. Clinicopathoiogical conference. Neurologic deterioration and death in a 27-year-old man with chondrosarcoma. Am J Med 1983; 74: 663–71
- Licciardello T J, Moake J L, Rudy C K, et al. Elevated plasma von Willebrand factor levels in arterial oclusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296–300
- Almenarez J A, Martin Jimenez M, Diaz Rubio E, Guerrero Sola A. Infarto cerebral tras la administración de cisplatino. Neoplasia 1985; 5: 226–7
- Nicholas J, Vogelzang M D, Jane L, et al. Hypomagnesemia, renal dysfunction and Raynaud's phenomenon in patients treated with cisplatin. vinblastine and bleomycin. Cancer 1985; 56: 2765–70
- Altura B M, Altura B T, Gebrewold A. Magnesium deficiency and hypertension. Correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315–7
- Samuels B L, Vogelzang N J, Kennedy B J. Severe vascular toxicity associated with vimblastine, bleomycin and cisplatin chemotherapy. Cancer Chemother Pharmacol 1987; 19: 253–6
- Kukla L J, McGuire W P, Lad T, Saltiel M. Acute vascular episodes associated with therapy for carcinomas of upper aerodigestive tract with bleomycin. vincristine and cisplatin. Cancer Treat Rep 1982; 66: 369–70
- Gerl A, Clemm C, Wilmanns W. Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer. Lancet 1991; 338: 385–6